Global Kidney Function Test Market

Kidney Function Test Market Size, Share, Growth Analysis, By Test(Clearance tests, Urine tests, Blood tests, Dilution and concentration tests), By Product(Dipsticks, Disposables, and Reagents), By End-use(Diagnostic laboratories, Hospital’s), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35D2206 | Region: Global | Published Date: July, 2027
Pages: 219 | Tables: 91 | Figures: 66

Kidney Function Test Market Insights

Kidney Function Test Market was valued at USD 842.1 million in 2022 and is expected to rise from USD 895.15 million in 2023 to reach a value of USD 1459.4 million by 2031, at a CAGR of 6.3% during the forecast period (2024–2031).

The Kidney function test market is poised for substantial growth, buoyed by several contributing factors that collectively propel advancements in this field. Notably, escalating investments by key market players and a concurrent surge in research and development activities are steering innovative strides in Kidney care. A significant driver is the high prevalence of kidney diseases, urging a proactive approach towards improved diagnostics and treatment. Additionally, the growing impetus from government initiatives further bolsters this momentum, fostering an environment conducive to transformative advancements.

One such example is Nova Biomedical's groundbreaking introduction in March 2022—a pioneering tool designed to revolutionize Kidney care by enabling early disease detection and renal function screening in Point-of-Care Testing (POCT) settings beyond hospital confines. The efficacy of this technology has been substantiated through clinical studies conducted across various non-hospital environments, encompassing community health centers, pharmacies, imaging centers, physician offices, clinics, and even home-based testing by individuals. This innovative leap promises to extend the reach of Kidney health assessment, empowering diverse settings with enhanced diagnostic capabilities and facilitating proactive measures for improved patient outcomes.

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.



Kidney Function Test Market was valued at USD 842.1 million in 2022 and is expected to rise from USD 895.15 million in 2023 to reach a value of USD 1459.4 million by 2031, at a CAGR of 6.3% during the forecast period (2024–2031).

The competitive environment of the kidney function test market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry.  'Abbott Laboratories (USA) ', 'Siemens Healthineers (Germany) ', 'Roche Diagnostics (Switzerland) ', 'Beckman Coulter Inc. (USA) ', 'Sysmex Corporation (Japan) ', 'Randox Laboratories Ltd. (UK) ', 'ACON Laboratories, Inc. (USA) ', 'Nova Biomedical (USA) ', 'ARKRAY, Inc. (Japan) ', '77 Elektronika Kft. (Hungary) ', 'Opti Medical Systems, Inc. (USA) ', 'Quest Diagnostics (USA) ', 'Ortho Clinical Diagnostics (USA) ', 'Merck KGaA (Germany) ', 'Danaher Corporation (USA) ', 'Bio-Rad Laboratories, Inc. (USA) ', 'LabCorp (USA) ', 'DiaSys Diagnostic Systems GmbH (Germany) ', 'Thermo Fisher Scientific Inc. (USA) ', 'URIT Medical Electronic Co., Ltd. (China)'

The Kidney function test market is poised to witness lucrative opportunities driven by technological advancements. One notable example is the groundbreaking innovation unveiled by Bloom Diagnostics in August 2022, introducing a smart system designed to detect an extensive array of medical disorders. Among its offerings, the Bloom Kidney Test stands out as the latest addition to its portfolio. This test revolutionizes Kidney health assessment by quantitatively measuring cystatin C levels in the bloodstream, facilitating the evaluation of Glomerular Filtration Rate (GFR) to determine Kidney functionality. Notably, the test provides a comprehensive assessment through three distinct classifications—indicating normal function, mildly decreased function, or decreased function—offering vital insights into Kidney health.  

The burgeoning demand for home diagnostics, particularly evident in the increased adoption of digital urinalysis, is driving notable growth within the market. This trend reflects a significant shift towards convenient and accessible healthcare solutions. Notably,, an Israeli-based digital health startup, has astutely recognized this trajectory and developed an FDA-cleared at-home smartphone urinalysis test tailored for individuals seeking Kidney tests for proteins.

In 2023, North America emerged as the revenue leader, asserting dominance within the market landscape. This stronghold can be attributed to several factors, notably the region's well-established healthcare infrastructure, coupled with a heightened awareness of chronic kidney disease (CKD) among both healthcare professionals and the general populace. Additionally, the region benefits from favorable reimbursement policies and proactive governmental initiatives aimed at bolstering healthcare accessibility and affordability. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.


Feedback From Our Clients

Global Kidney Function Test Market

Report ID: SQMIG35D2206